Watch Ticker

Ultragenyx Pharmaceutical Inc.

Go to Ultragenyx Pharmaceutical Inc. Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$3.4 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic dise...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

NOVATO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that Eric Crombez, M.D., the company's chief medical officer and executive vice president, will participate in a fireside at Bank of America’s 2024 Healthcare Conference on Tuesday, May 14, 2024, at 1:40 p.m. PT.

Related tickers: RARE.

Read Full Article

Ultragenyx (RARE) reports dismal first-quarter 2024 results, missing both earnings and revenue estimates, despite the year-over-year increase of Crysvita and Dojolvi sales.

Related tickers: REGN, LGND, ANIP, RARE.

Read Full Article
Trending Tickers
BTTX

XNAS

$0.00
(%)
OPRT

XNAS

$0.00
(%)
PALI

XNAS

$6.24
(%)
PRSO

XNAS

$1.42
(%)
ACRV

XNAS

$8.36
(%)